(VIANEWS) - Workhorse Group (WKHS), Huntington Bancshares (HBAN), PGT (PGTI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Workhorse Group (WKHS)
1154.6% sales growth and 42.3% return on equity
Workhorse Group Inc., a technology company, designs, manufactures, builds, and sells battery-electric vehicles and aircraft in the United States.
Workhorse Group's sales growth this year is anticipated to be 952.4% and 663% for next year.
Year-on-year quarterly revenue growth grew by 1208.3%, now sitting on 2.94M for the twelve trailing months.
Volume
Today's last reported volume for Workhorse Group is 3138820 which is 61.42% below its average volume of 8136210.
Workhorse Group's sales growth for the next quarter is 1154.6%. The company's growth estimates for the ongoing quarter and the next is 55.1% and negative -103.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.3%.
Volatility
Workhorse Group's last day, last week, and last month's current intraday variation average was 7.73%, 3.88%, and 3.93%, respectively.
Workhorse Group's highest amplitude of average volatility was 8.45% (day), 6.48% (last week), and 7.93% (last month), respectively.
Workhorse Group's Stock Yearly Top and Bottom Value
Workhorse Group's stock is valued at $5.26 at 10:22 EST, way under its 52-week high of $42.96 and way higher than its 52-week low of $4.38.
Workhorse Group's Moving Average
Workhorse Group's worth is way under its 50-day moving average of $6.01 and way below its 200-day moving average of $9.80.2. Huntington Bancshares (HBAN)
37.6% sales growth and 6.92% return on equity
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
Huntington Bancshares's sales growth this year is expected to be 24.8% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 4.69B for the twelve trailing months.
Volume
Today's last reported volume for Huntington Bancshares is 2027580 which is 79.01% below its average volume of 9664280.
Huntington Bancshares's sales growth is a negative 0% for the present quarter and 37.6% for the next. The company's growth estimates for the present quarter and the next is 22.2% and 25.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.92%.
Volatility
Huntington Bancshares's last day, last week, and last month's current intraday variation average was 0.12%, 2.26%, and 1.21%, respectively.
Huntington Bancshares's highest amplitude of average volatility was 1.77% (day), 2.95% (last week), and 2.36% (last month), respectively.
Huntington Bancshares's Stock Yearly Top and Bottom Value
Huntington Bancshares's stock is valued at $16.69 at 10:22 EST, under its 52-week high of $16.91 and way higher than its 52-week low of $12.00.
Huntington Bancshares's Moving Average
Huntington Bancshares's value is higher than its 50-day moving average of $15.93 and above its 200-day moving average of $15.34.3. PGT (PGTI)
25.3% sales growth and 5.54% return on equity
PGT Innovations, Inc., together with its subsidiaries, manufactures and supplies impact-resistant residential windows and doors in the Southeastern United States, Western United States, the Gulf Coast, Coastal mid-Atlantic, the Caribbean, Central America, and Canada.
PGT's sales growth this year is anticipated to be 31.2% and 19.6% for next year.
Year-on-year quarterly revenue growth grew by 26.2%, now sitting on 1.08B for the twelve trailing months.
Volume
Today's last reported volume for PGT is 165865 which is 35.26% below its average volume of 256207.
PGT's sales growth for the next quarter is 25.3%. The company's growth estimates for the ongoing quarter and the next is 61.1% and 37%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.54%.
Volatility
PGT's last day, last week, and last month's current intraday variation average was 3.11%, 3.29%, and 2.06%, respectively.
PGT's highest amplitude of average volatility was 3.39% (day), 4.20% (last week), and 3.28% (last month), respectively.
PGT's Stock Yearly Top and Bottom Value
PGT's stock is valued at $22.20 at 10:22 EST, way below its 52-week high of $28.11 and way above its 52-week low of $18.81.
PGT's Moving Average
PGT's worth is higher than its 50-day moving average of $21.47 and under its 200-day moving average of $22.71.4. Towers Watson & Co (TW)
16.5% sales growth and 5.52% return on equity
Tradeweb Markets Inc. builds and operates electronic marketplaces in the United States, Europe, Asia, and internationally.
Towers Watson & Co's sales growth this year is anticipated to be 19.6% and 10.6% for next year.
Year-on-year quarterly revenue growth grew by 24.7%, now sitting on 1.03B for the twelve trailing months.
Volume
Today's last reported volume for Towers Watson & Co is 107714 which is 81.84% below its average volume of 593231.
Towers Watson & Co's sales growth for the next quarter is 16.5%. The company's growth estimates for the current quarter and the next is 26.7% and 20.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.52%.
Towers Watson & Co's Stock Yearly Top and Bottom Value
Towers Watson & Co's stock is valued at $90.57 at 10:22 EST, below its 52-week high of $99.25 and way higher than its 52-week low of $59.35.
Towers Watson & Co's Moving Average
Towers Watson & Co's worth is under its 50-day moving average of $90.82 and above its 200-day moving average of $84.46.5. International Paper Company (IP)
13.2% sales growth and 21.53% return on equity
International Paper Company operates as a paper and packaging company primarily in United States, the Middle East, Europe, Africa, Pacific Rim, Asia, and the Americas.
International Paper Company's sales growth this year is anticipated to be 10% and 2.9% for next year.
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 21.93B for the twelve trailing months.
Volume
Today's last reported volume for International Paper Company is 356181 which is 89.68% below its average volume of 3452460.
International Paper Company's sales growth for the next quarter is 13.2%. The company's growth estimates for the ongoing quarter and the next is 112.7% and 102.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.53%.
Volatility
International Paper Company's last day, last week, and last month's current intraday variation average was 0.45%, 1.70%, and 0.71%, respectively.
International Paper Company's highest amplitude of average volatility was 2.02% (day), 2.26% (last week), and 1.51% (last month), respectively.
International Paper Company's Stock Yearly Top and Bottom Value
International Paper Company's stock is valued at $48.85 at 10:22 EST, way below its 52-week high of $61.81 and way above its 52-week low of $44.02.
International Paper Company's Moving Average
International Paper Company's worth is below its 50-day moving average of $50.23 and under its 200-day moving average of $54.19.6. WD-40 Company (WDFC)
7.7% sales growth and 38.94% return on equity
WD-40 Company develops and sells maintenance products, and homecare and cleaning products in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
WD-40 Company's sales growth this year is expected to be 7.5% and 5.6% for next year.
Year-on-year quarterly revenue growth grew by 3.2%, now sitting on 488.11M for the twelve trailing months.
Volume
Today's last reported volume for WD-40 Company is 94134 which is 11.94% below its average volume of 106906.
WD-40 Company's sales growth is a negative 0% for the ongoing quarter and 7.7% for the next. The company's growth estimates for the present quarter and the next is a negative 27.3% and negative -16.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.94%.
Volatility
WD-40 Company's last day, last week, and last month's current intraday variation average was 3.16%, 2.28%, and 1.72%, respectively.
WD-40 Company's highest amplitude of average volatility was 4.39% (day), 3.58% (last week), and 2.94% (last month), respectively.
WD-40 Company's Stock Yearly Top and Bottom Value
WD-40 Company's stock is valued at $245.04 at 10:22 EST, way under its 52-week high of $333.42 and way higher than its 52-week low of $207.11.
WD-40 Company's Moving Average
WD-40 Company's worth is higher than its 50-day moving average of $231.86 and under its 200-day moving average of $246.73.7. Masonite International Corporation Ordinary Shares (DOOR)
6.3% sales growth and 21.87% return on equity
Masonite International Corporation designs, manufactures, markets, and distributes interior and exterior doors for the new construction and repair, renovation, and remodeling sectors of the residential and non-residential building construction markets worldwide.
Masonite International Corporation Ordinary Shares's sales growth this year is anticipated to be 16.1% and 7.6% for next year.
Year-on-year quarterly revenue growth grew by 11%, now sitting on 2.58B for the twelve trailing months.
Volume
Today's last reported volume for Masonite International Corporation Ordinary Shares is 39063 which is 70.87% below its average volume of 134115.
Masonite International Corporation Ordinary Shares's sales growth for the next quarter is 6.3%. The company's growth estimates for the current quarter and the next is 54% and 15%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.87%.
Volatility
Masonite International Corporation Ordinary Shares's last day, last week, and last month's current intraday variation average was 0.97%, 0.66%, and 1.58%, respectively.
Masonite International Corporation Ordinary Shares's highest amplitude of average volatility was 2.54% (day), 1.65% (last week), and 2.53% (last month), respectively.
Masonite International Corporation Ordinary Shares's Stock Yearly Top and Bottom Value
Masonite International Corporation Ordinary Shares's stock is valued at $117.95 at 10:22 EST, way below its 52-week high of $132.22 and way above its 52-week low of $92.76.
Masonite International Corporation Ordinary Shares's Moving Average
Masonite International Corporation Ordinary Shares's value is higher than its 50-day moving average of $115.71 and above its 200-day moving average of $116.21.8. Royalty Pharma (RPRX)
6.2% sales growth and 15.4% return on equity
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
Royalty Pharma's sales growth this year is anticipated to be 5.6% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.29B for the twelve trailing months.
Volume
Today's last reported volume for Royalty Pharma is 126777 which is 93.78% below its average volume of 2040140.
Royalty Pharma's sales growth for the next quarter is 6.2%. The company's growth estimates for the current quarter and the next is 41.7% and 171.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.4%.
Royalty Pharma's Stock Yearly Top and Bottom Value
Royalty Pharma's stock is valued at $38.35 at 10:22 EST, way under its 52-week high of $53.23 and way higher than its 52-week low of $34.86.
Royalty Pharma's Moving Average
Royalty Pharma's worth is under its 50-day moving average of $38.89 and under its 200-day moving average of $40.64.Previous days news about Royalty Pharma(RPRX)
- Royalty pharma to present at the J.P. Morgan healthcare conference on January 10. According to Benzinga on Wednesday, 5 January, "NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET.", "Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. "